BOM:531349 (India)
Â
Shs Dematerialised
₹
537.7
-3.75 (-0.69%)
Jul 14
Business Description
Panacea Biotec Ltd
ISIN : INE922B01023
Share Class Description:
BOM:531349: Shs DematerialisedTotal Employee Number:
2,504Compare
Compare
Traded in other countries / regions
531349.India IPO Date
2000-09-18Description
Panacea Biotec Ltd is a Biotechnology company. It is engaged in the business of research, development, manufacturing, and marketing of branded pharmaceutical formulations, vaccines, and biopharmaceuticals. The company's operating segments include Vaccines, and Formulations. It generates maximum revenue from the Vaccines segment. The company product portfolio includes prescription products in niche therapeutic areas such as diabetes and cardiovascular management, oncology, nephrology and transplant management, osteoporosis management, gastro-intestinal care, pain management products, and pediatric immunization. The group has a business presence in India and Outside India.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 5.69 | |||||
Equity-to-Asset | 0.66 | |||||
Debt-to-Equity | 0.03 | |||||
Debt-to-EBITDA | 0.75 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 5.3 | |||||
Beneish M-Score | -2.32 | |||||
WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 12 | |||||
3-Year EBITDA Growth Rate | -17 | |||||
3-Year EPS without NRI Growth Rate | 38.9 | |||||
3-Year FCF Growth Rate | 56.7 | |||||
3-Year Book Growth Rate | -0.3 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 43.68 | |||||
9-Day RSI | 49.37 | |||||
14-Day RSI | 53.8 | |||||
3-1 Month Momentum % | 62.28 | |||||
6-1 Month Momentum % | 36.03 | |||||
12-1 Month Momentum % | 26.45 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.47 | |||||
Quick Ratio | 0.92 | |||||
Cash Ratio | 0.39 | |||||
Days Inventory | 261.05 | |||||
Days Sales Outstanding | 42.27 | |||||
Days Payable | 260.55 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shareholder Yield % | -0.15 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 56.16 | |||||
Operating Margin % | -5.9 | |||||
Net Margin % | -0.84 | |||||
EBITDA Margin % | 4.96 | |||||
FCF Margin % | -5.85 | |||||
OCF Margin % | 2.61 | |||||
ROE % | -0.65 | |||||
ROA % | -0.42 | |||||
ROIC % | -3.95 | |||||
ROC (Joel Greenblatt) % | -0.19 | |||||
ROCE % | -0.14 | |||||
Years of Profitability over Past 10-Year | 2 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shiller PE Ratio | 32.73 | |||||
PS Ratio | 5.23 | |||||
PB Ratio | 3.94 | |||||
Price-to-Tangible-Book | 4.2 | |||||
Price-to-Operating-Cash-Flow | 196.75 | |||||
EV-to-EBIT | -2406.43 | |||||
EV-to-EBITDA | 100.09 | |||||
EV-to-Revenue | 4.96 | |||||
EV-to-FCF | -86.37 | |||||
Price-to-GF-Value | 1.49 | |||||
| Price-to-Net-Current-Asset-Value | 38.43 | |||||
Earnings Yield (Greenblatt) % | -0.04 | |||||
FCF Yield % | -1.14 | |||||
Forward Rate of Return (Yacktman) % | -42.44 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Panacea Biotec Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 6,397.7 | ||
| EPS (TTM) (₹) | -0.88 | ||
| Beta | 1.6172 | ||
| 3-Year Sharpe Ratio | 0.94 | ||
| 3-Year Sortino Ratio | 2.26 | ||
| Volatility % | 53.36 | ||
| 14-Day RSI | 53.8 | ||
| 14-Day ATR (₹) | 29.274072 | ||
| 20-Day SMA (₹) | 544.2175 | ||
| 12-1 Month Momentum % | 26.45 | ||
| 52-Week Range (₹) | 293.1 - 647.5 | ||
| Shares Outstanding (Mil) | 61.25 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Panacea Biotec Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Panacea Biotec Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| 10:1 Stock Split | 2003-02-03 | 2.26 (+0.00%) |
Show
Entries
Panacea Biotec Ltd Frequently Asked Questions
What is Panacea Biotec Ltd(BOM:531349)'s stock price today?
The current price of BOM:531349 is ₹537.70. The 52 week high of BOM:531349 is ₹647.50 and 52 week low is ₹293.10.
When is next earnings date of Panacea Biotec Ltd(BOM:531349)?
The next earnings date of Panacea Biotec Ltd(BOM:531349) is .
Does Panacea Biotec Ltd(BOM:531349) pay dividends? If so, how much?
Panacea Biotec Ltd(BOM:531349) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Panacea Biotec Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers